Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.

@article{Gerbutaviius2003DifferentialEO,
  title={Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.},
  author={Rolandas Gerbutavi{\vc}ius and Omer J. Iqbal and Harry L. Messmore and William H. Wehrmacher and Debra A. Hoppensteadt and Rima Jūrate Gerbutaviciene and Rasa Griniūte and Jawed Fareed},
  journal={Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis},
  year={2003},
  volume={9 4},
  pages={317-23}
}
New synthetic direct and indirect factor Xa or factor IIa inhibitors are increasingly used for the prevention and treatment of thrombotic disorders, including patients suffering from antiphospholipid syndrome. In this study, the effects of the synthetic direct factor Xa inhibitor DX-9065a, the indirect synthetic heparinomimetic pentasaccharide, and the… CONTINUE READING